| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/02/2005 | CN1187054C Osmosis pump controlled release preparation containing Chinese medicine of cyclovirobuxine D, and preparing method thereof |
| 02/02/2005 | CN1187052C Sustained release microsphere containing stavudine |
| 02/02/2005 | CN1187049C Patches containing buprenorphine |
| 02/02/2005 | CN1187044C Storable active substance concentrate containing formoterol |
| 02/02/2005 | CN1187042C Plaster which contains steroids and its production method and uses |
| 02/02/2005 | CN1187041C Slow released parts of volatile medicine |
| 02/02/2005 | CN1187040C Anti-heatstroke effervescent tablet |
| 02/02/2005 | CN1187039C High potency dihydroergotamine compositions |
| 02/01/2005 | US6849655 Aqueous liquid formulations |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849616 Use of estramustine phosphate, a non-nitrogen mustard carbamate derivative of estradiol-17b-phosphate, as a high dose infusion for cancer treatment; also can be used in combination with other chemotherapeutic agents |
| 02/01/2005 | US6849609 Method and composition for controlled release acarbose formulations |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849463 Microarray; diagnostic and detection; storage and protection of chemicals and smaller secondary devices from environmental exposure |
| 02/01/2005 | US6849286 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants |
| 02/01/2005 | US6849274 Mixture of anhydrous calcium lactate; calcium oxide and anhydrous or calcined magnesium sulfate which, when added to a food containing releasably bound water, provides a dessicating effect |
| 02/01/2005 | US6849271 For sustained release of drugs |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | US6849269 Enteric-coated mixture of a poorly water soluble drug and a phospholipid |
| 02/01/2005 | US6849263 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/01/2005 | US6849253 Use of borate-polyol complexes in ophthalmic compositions |
| 02/01/2005 | US6849109 Multimetallic nanofillers with domain size less than 100 nanometers exhibiting transparency to visible light that differs by more than 20% as compared to fillers having a domain size of at least one micron. |
| 02/01/2005 | US6848211 Cultivated agarwood |
| 02/01/2005 | US6848197 Spray dried particles having specified aerodynamic characteristics are produced by atomizing a liquid feed and contacting the liquid feed with a drying gas, such as, for example, air or nitrogen. |
| 02/01/2005 | CA2419729C Crystal form ii of clarithromycin |
| 02/01/2005 | CA2296080C Ophthalmic compositions containing galactomannan polymers and borate |
| 02/01/2005 | CA2270074C Electrically conductive adhesive hydrogels |
| 02/01/2005 | CA2193770C A toxin decontaminant food product and method of forming same |
| 02/01/2005 | CA2171612C Antioxidant-containing effervescent composition |
| 02/01/2005 | CA2147281C Method and compositions for removing an alginate from a cutaneous substrate |
| 02/01/2005 | CA2133324C Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 02/01/2005 | CA2083159C The combination of growth hormone and insulin-like growth factor-1 enhances growth |
| 01/31/2005 | CA2475968A1 A coating for implantable medical devices to control drug elution from abasecoat |
| 01/27/2005 | WO2005007819A2 Charge-dynamic polymers and delivery of anionic compounds |
| 01/27/2005 | WO2005007802A2 Fibrous composite for tissue engineering |
| 01/27/2005 | WO2005007640A1 Preventive or therapeutic composition for viral infectious disease |
| 01/27/2005 | WO2005007599A2 Hydroxyapatite calcium phosphate granules, method for preparing same and uses thereof |
| 01/27/2005 | WO2005007284A2 Composite nanoparticles |
| 01/27/2005 | WO2005007223A2 Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
| 01/27/2005 | WO2005007196A2 Lipid encapsulated interfering rna |
| 01/27/2005 | WO2005007195A1 Poly-4-hydroxybutyrate matrices for sustained drug delivery |
| 01/27/2005 | WO2005007194A1 Semi-solid mucoadhesive formulations |
| 01/27/2005 | WO2005007185A2 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 01/27/2005 | WO2005007172A1 Glycoside-containing liposome |
| 01/27/2005 | WO2005007169A2 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | WO2005007168A1 A stable clozapine suspension formulation |
| 01/27/2005 | WO2005007167A1 Solid pharmaceutical preparation |
| 01/27/2005 | WO2005007161A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 01/27/2005 | WO2005007142A2 Liquid compositions comprising formoterol |
| 01/27/2005 | WO2005007139A2 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 01/27/2005 | WO2005007138A1 Pharmaceutical formulations |
| 01/27/2005 | WO2005007137A2 Tablets containing ambroxol |
| 01/27/2005 | WO2005007136A1 Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 01/27/2005 | WO2005007135A1 Pharmaceutical compositions |
| 01/27/2005 | WO2005007134A1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 01/27/2005 | WO2005007133A1 Structured surfactant systems |
| 01/27/2005 | WO2005007132A1 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 01/27/2005 | WO2005007131A2 Propofol formulations with non-reactive container closures |
| 01/27/2005 | WO2005007130A1 Stable pharmaceutical compositions containing an ace inhibitor |
| 01/27/2005 | WO2005007129A2 Topical formulations with bioactive components |
| 01/27/2005 | WO2005007122A2 Polymer stabilization |
| 01/27/2005 | WO2005007117A2 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| 01/27/2005 | WO2005007115A2 Pharmaceutical composition for inhibiting acid secretion |
| 01/27/2005 | WO2005007110A2 Compositions and methods for hydrophobic drug delivery |
| 01/27/2005 | WO2005007108A2 Asymmetric disulfides and methods of using same |
| 01/27/2005 | WO2005007107A2 Histamine and cck2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer |
| 01/27/2005 | WO2005007105A2 Pharmaceutical compositions |
| 01/27/2005 | WO2005007102A2 Phytochemicals for the treatment of mastalgia, endometriosis and hpv-related conditions including cervical dysplasia |
| 01/27/2005 | WO2005007098A2 Nucleic acid therapy to enhance cartilage repair |
| 01/27/2005 | WO2005007082A2 Treatment of chronic bacterial infection |
| 01/27/2005 | WO2005007080A2 Methods and compositions for delivery of catecholic butanes for treatment of tumors |
| 01/27/2005 | WO2005007074A2 Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
| 01/27/2005 | WO2005007069A2 Soft gel formulations for saquinavir |
| 01/27/2005 | WO2005007068A1 Nicotine packaging system |
| 01/27/2005 | WO2004105728A3 Solid dispersions of cefpodoxime proxetil and processes for their preparation |
| 01/27/2005 | WO2004100894A3 Drug formulations having reduced abuse potential |
| 01/27/2005 | WO2004093884A3 High drug load mesalazine sachet |
| 01/27/2005 | WO2004091578A8 Novel encochleation methods, cochleates and methods of use |
| 01/27/2005 | WO2004091528A3 Delivery systems of homogeneous thermoreversible alginate films |
| 01/27/2005 | WO2004087043B1 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 01/27/2005 | WO2004084861A3 Angiogenesis promotion by prostaglandin compositions and methods |
| 01/27/2005 | WO2004082580A3 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/27/2005 | WO2004081222A3 Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
| 01/27/2005 | WO2004073584A3 Cystitis treatment with high dose chondroitin sulfate |
| 01/27/2005 | WO2004070017A3 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
| 01/27/2005 | WO2004064757A3 Absorption enhancing agents |
| 01/27/2005 | WO2004060878A3 Inhibitors of phosphatases |
| 01/27/2005 | WO2004032644A3 Chewing gum formulation and method of making the same |
| 01/27/2005 | WO2004010998A8 Sustained-release tablet comprising reboxetine |
| 01/27/2005 | US20050021174 Method and system for producing customized cosmetic and pharmaceutical formulations on demand |
| 01/27/2005 | US20050021009 Intravaginal devices containing progesterone for estrus synchronization and related proceses |
| 01/27/2005 | US20050021008 Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves |
| 01/27/2005 | US20050021007 Infusion system for creating micro-environments in a living body |
| 01/27/2005 | US20050021006 Infusion pump comprising a computer for calculating the respective maximum permissible dosage |
| 01/27/2005 | US20050021005 Laminated patient infusion device |
| 01/27/2005 | US20050020996 Method and apparatus to control drug therapy dosages in an implantable pump |
| 01/27/2005 | US20050020993 Administration of therapeutic or diagnostic agents using interlabial pad |
| 01/27/2005 | US20050020931 Management of gastro-intestinal disorders |
| 01/27/2005 | US20050020923 Materials and methods for near-infrared and infrared lymph node mapping |
| 01/27/2005 | US20050020854 For use as cleaning and foaming agents and as emulsifiers |